Equities in Canada’s largest centre went for a slide Friday, as resource issues bore much of the brunt of investor indifference. The TSX tumbled 280.33 points to 36,663.92. On the week, however, the ...

Stocks slipped in Toronto after being spooked by remarks from Fed Chair Kevin Warsh Friday. The TSX had fallen 144.96 points by noon ET to 36,689.29. On the week so far, the index remained buoyant 69 ...

Equity markets north of the border shared the downward sentiment Wednesday, as resources provided the anchor. The TSX swooned 143.98 points to end Wednesday’s session at 36,813.65 The Canadian dollar ...

Bitcoin (BTC) appears to be growing more correlated with gold bullion as markets are gyrated by geopolitical events and volatility in the bond market. TradingView data shows that Bitcoin’s 30-day ...

Oil volumes moving out of the Persian Gulf have recovered to about two-thirds of the typical levels from before the Iran war, Goldman Sachs says, noting that the jump in exports could cap oil prices ...

SpaceX (SPCX) has announced plans to build a $100 billion U.S. launch facility in the State of Louisiana. In a statement, ...

Hit a new 52-Week High of 48 cents. In mid-August, Diagnos received Medical Device Marketing Authorization for the CARA ...

A federal judge has ruled that the Trump administration’s blacklisting of artificial intelligence (A.I.) startup Anthropic on national security concerns was illegal. U.S. District Court Judge Rita Lin ...

Canada’s economy returned to growth in the year’s second quarter after contracting in the previous two quarters and sending the economy into a brief, shallow recession. Statistics Canada said that ...

The stock of Abercrombie & Fitch (ANF) is up 10% after the U.S. clothing retailer delivered better-than-expected financial results. For the year’s second quarter, Abercrombie & Fitch posted earnings ...

ENvue Medical, Inc. (NASDAQ: FEED), a commercial-stage medical technology company, today announced that a reverse stock split of the Company’s issued and outstanding common stock, par value $0.001 per ...

Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced it has made a bid to acquire an innovative neuroscience product from BioXcel ...